Fesoterodine Fumarate
16 NDCs across 8 manufacturers|14 Generic,2 Brand
Fesoterodine Fumarate is used to treat urge urinary incontinence, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Oct 31, 2008, and the first generic was approved Dec 10, 2015. FDA's Orange Book lists 16 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $21 million on Fesoterodine Fumarate across 169,000 claims for 39,000 beneficiaries.
Fesoterodine Fumarate is available as 16 NDCs from 8 manufacturers (14 generic, 2 brand), with NADAC prices from $0.79 to $9.27 per EA — the most expensive product costs about 12× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
16
14G / 2B
Manufacturers
8
competing in market
Price Spread
$0.79 – $9.27
per EA
7d Activity
avg -0.6% WoW · of 16 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
8 manufacturers producing FESOTERODINE FUMARATE(1 pricing outlier)
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
TOVIAZ ER 8 MG TABLET | $9.2652 per EA | +0.03% |
TOVIAZ ER 4 MG TABLET | $9.2623 per EA | +0.04% |
FESOTERODINE ER 8 MG TABLET | $0.8127 per EA | -1.43% |
FESOTERODINE ER 8 MG TABLET | $0.8127 per EA | -1.43% |
FESOTERODINE ER 8 MG TABLET | $0.8127 per EA | -1.43% |
FESOTERODINE ER 8 MG TABLET | $0.8127 per EA | -1.43% |
FESOTERODINE ER 8 MG TABLET | $0.8127 per EA | -1.43% |
FESOTERODINE ER 8 MG TABLET | $0.8127 per EA | -1.43% |
FESOTERODINE ER 8 MG TABLET | $0.8127 per EA | -1.43% |
FESOTERODINE ER 4 MG TABLET | $0.7909 per EA | +0.16% |
FESOTERODINE ER 4 MG TABLET | $0.7909 per EA | +0.16% |
FESOTERODINE ER 4 MG TABLET | $0.7909 per EA | +0.16% |
FESOTERODINE ER 4 MG TABLET | $0.7909 per EA | +0.16% |
FESOTERODINE ER 4 MG TABLET | $0.7909 per EA | +0.16% |
FESOTERODINE ER 4 MG TABLET | $0.7909 per EA | +0.16% |
FESOTERODINE ER 4 MG TABLET | $0.7909 per EA | +0.16% |
Frequently Asked Questions
What is Fesoterodine Fumarate used to treat?
Fesoterodine Fumarate is used to treat urge urinary incontinence, per the National Library of Medicine's MED-RT classification.
When did Fesoterodine Fumarate become available as a generic?
FDA approved the first generic Fesoterodine Fumarate (ANDA) on Dec 10, 2015. The Orange Book currently lists 16 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Fesoterodine Fumarate?
In 2024, Medicare Part D spent $21 million on Fesoterodine Fumarate across 169,000 claims for 39,000 beneficiaries.
How many Fesoterodine Fumarate products are on the market?
The Fesoterodine Fumarate drug market contains 16 NDCs from 8 manufacturers — 14 generic and 2 brand products.
What is the price range for Fesoterodine Fumarate?
NADAC reference prices for Fesoterodine Fumarate range from $0.7909 to $9.2652 per EA — the most expensive product costs about 12× the cheapest.
Is generic Fesoterodine Fumarate cheaper than brand?
The average generic NADAC for Fesoterodine Fumarate is $0.8018 per EA, versus $9.2638 for brand-labeled products — brand versions average about 12× the generic price.
Which manufacturers make Fesoterodine Fumarate?
8 manufacturers list Fesoterodine Fumarate in NADAC. Ranked by number of NDCs, the largest are Pfizer Inc. (2), NorthStar Rx LLC (2), Camber Pharmaceuticals Inc. (2), Dr. Reddy's Laboratories Inc. (2), Alembic Pharmaceuticals Inc. (2).
How has the price of Fesoterodine Fumarate changed recently?
Over the past 7 days, 9 Fesoterodine Fumarate NDCs rose and 7 fell, with a market-wide average change of -0.6%.